Are thyroid cancer patients sensitive to ionising radiation?

International Journal of Radiation Biology

Volumn 87, Issue 9, 2011, Pages 932-935

  García Quispes, Wilser Andrés ^a   Pérez Machado, Giselle ^a,e   Sandoval, Berenice ^a   Pastor, Susana ^a,b   Velázquez, Antonia ^a,b   Galofré, Pere ^c,d   Biarnés, Josefina ^d   Castell, Joan ^c   Marcos, Ricard ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

^e CENTRAL UNIVERSITY OF LAS VILLAS   (Cuba)

Author keywords

Micronuclei; Radiosensitivity; Thyroid cancer patients

Indexed keywords

CESIUM 137; CYTOCHALASIN B; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL CYCLE G0 PHASE; CONTROLLED STUDY; CYTOKINESIS BLOCK MICRONUCLEUS TEST; DIFFERENTIATED THYROID CANCER; FEMALE; GAMMA RADIATION; HUMAN; HUMAN CELL CULTURE; IONIZING RADIATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; CELL DIFFERENTIATION; CYTOKINESIS; DNA DAMAGE; GENOMIC INSTABILITY; METABOLISM; MICRONUCLEUS TEST; MIDDLE AGED; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE; THYROID TUMOR;

ADULT; AGED; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CYTOKINESIS; DNA DAMAGE; FEMALE; GENOMIC INSTABILITY; HUMANS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; RADIATION TOLERANCE; THYROID NEOPLASMS;

EID: 80054781207     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2011.577507     Document Type: Article

References (32)

1. Baeyens A, Slabbert JP, Willem P, Jozela S, Van Der Merwe D, Vral A. 2010. Chromosomal radiosensitivity of HIV positive individuals. International Journal of Radiation Biology 86:584-592.
2. Ballardin M, Gemignani F, Bodei L, Mariani G, Ferdeghini M, Rossi AM, Migliore L, Barale R. 2002. Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Mutation Research 514:77-85. (Pubitemid 34114081)
3. Bonassi S, Neri M, Puntoni R. 2001. Validation of biomarkers as early predictors of disease. Mutation Research 480-481:349-358.
4. Brent GA, Braverman LE, Zoeller RT. 2007. Th yroid health and the environment. Th yroid 17:807-809.
5. Chistiakov DA, Voronova NV, Chistiakov PA. 2008. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncologica 47:809-824. (Pubitemid 351882749)
6. Curwen GB, Murphy S, Tawn EJ, Winther JF, Boice JD. 2011. A study of DNA damage recognition and repair gene polymorphisms in relation to cancer predisposition and G2 chromosomal radiosensitivity. Environmental and Molecular Mutagenesis 52:72-76.
7. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S. 2009. Risk factors for thyroid cancer: An epidemiological review focused on nutritional factors. Cancer Causes Control 20:75-86.
8. Decordier I, Papine A, Plas G, Roesems S, Vande Loock K, Moreno- Palomo J, Cemeli E, Anderson D, Fucic A, Marcos R, Soussaline F, Kirsch-Volders M. 2009. Automated image analysis of cytokinesisblocked micronuclei: An adapted protocol and a validated scoring procedure for biomonitoring. Mutagenesis 24:85-93.
9. El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, Spitz MR. 2006. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Research 66:6449-6456.
10. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E. 2003. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocytes cultures. Mutation Research 534:65-75. (Pubitemid 36015839)
11. Fenech M. 2002. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discovery Today 7:1128-1137. (Pubitemid 35346420)
12. Fenech M. 2000. Th e in vitro micronucleus technique. Mutation Research 455:81-95.
13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127:2893-2917.
14. Gatzidou E, Michailidi C, Tseleni-Balafouta S, Th eocharis S. 2010. An epitome of DNA repair related genes and mechanisms in thyroid carcinoma. Cancer Letters 290:139-147.
15. Hernández A, Xamena N, Gutiérrez S, Velázquez A, Creus A, Surrallés J, Galofré P, Marcos R. 2006. Basal and induced micronucleus frequencies in human lymphocytes with diff erent GST and NAT2 genetic backgrounds. Mutation Research 606:12-20. (Pubitemid 43767348)
16. Howe O, Daly P, Seymour C, Ormiston W, Nolan C, Mothersill C. 2005. Elevated G2 chromosomal radiosensitivity in Irish breast cancer patients: A comparison with other studies. International Journal of Radiation Biology 81:373-378. (Pubitemid 41117007)
17. Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsiere T. 2007. Genetic polymorphisms and micronucleus formation: A review of the literature. Mutation Research 658:215-253.
18. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr, Lorge E, Norppa H, Surralles J, von der Hude W, Wakata A. 2000. Report from the In Vitro Micronucleus Assay Working Group. Environmental and Molecular Mutagenesis 35:167-172.
19. Lassmann M, Hanscheid H, Gassen D, Biko J, Meineke V, Reiners C, Scherthan H. 2010. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of diff erentiated thyroid cancer. Journal of Nuclear Medicine 51:1318-1325.
20. Mozdarani H, Mansouri Z, Haeri SA. 2005. Cytogenetic radio-sensitivity of G0-lymphocytes of breast and esophageal cancer patients as determined by micronucleus assay. Journal of Radiation Research (Tokyo) 46:111-116. (Pubitemid 40780156)
21. Murgia E, Ballardin M, Bonassi S, Rossi AM, Barale R. 2008. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutation Research 639:27-34.
22. Olive PL, Banath JP. 2004. Phosphorylation of histone H2AX as a measure of radiosensitivity. International Journal of Radiation Oncology. *Biology. *Physics 58:331-335. (Pubitemid 38142456)
23. Pitt SC, Moley JF. 2010. Medullary, anaplastic, and metastatic cancers of the thyroid. Seminars in Oncology 37:567-379.
24. Poggioli T, Sterpone S, Palma S, Cozzi R, Testa A. 2010. G0 and G2 chromosomal assays in the evaluation of sensitivity in a cohort of Italian breast cancer patients. Journal of Radiation Research 51:615-619.
25. Sterpone S, Cornetta T, Padua L, Mastellone V, Giammarino D, Testa A, Tirindelli D, Cozzi R, Donatto V. 2010. DNA repair capacity and acute radiotherapy adverse eff ects in Italian breast cancer patients. Mutation Research 684:43-48.
26. Schonfeld SJ, Lee C, Berrington de Gonzalez A. 2011. Medical exposure to radiation and thyroid cancer. Clinical Oncology Feb 4. 23:244-250.
27. Scott D. 2004. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenetics and Genome Research 104:365-370. (Pubitemid 38721104)
28. Scott D, Barber JB, Levine EL, Burrill W, Roberts SA. 1998. Radiationinduced micronucleus induction in lymphocytes identifi es a high frequency of radiosensitive cases among breast cancer patients: A test for predisposition? British Journal of Cancer 77:614-620. (Pubitemid 28059469)
29. Tucker JD, Eastmond DA, Littlefi eld LG. 1997. Cytogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies. IARC Scientifi c Publications 142:185-200.
30. Vral A, Fenech M, Th ierens H. 2011. Th e micronucleus assay as a biological dosimeter of in vivo ionising radiation exposure. Mutagenesis 26:11-17.
31. Volpato CB, Martínez-Alfaro M, Corvi R, Gabus C, Sauvaigo S, Ferrari P, Bonora E, De Grandi A, Romeo G. 2008. Enhanced sensitivity of the RET proto-oncogene to ionizing radiation in vitro. Cancer Research 68:8986-8992.
32. Znaor A, Fǔcić A, Strnad M, Barković D, Š kara M, Hozo I. 2003. Micronuclei in peripheral blood lymphocytes as a possible cancer risk biomarker: A cohort study of occupationally exposed workers in Croatia. Croatian Medical Journal 44:441-446. (Pubitemid 37092803)